Fatty Acid Compositions for Ketosis Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current compositions for managing ketone body levels in the blood, particularly for therapeutic ketosis, suffer from variability in blood concentrations, leading to ineffective or adverse side effects due to restrictive ketogenic diets and exogenous ketone supplements, necessitating compositions that provide sustained and controlled release.
Innovation Solution
A combination of a first composition containing butyric acid, caproic acid, and optionally acetic acid, and a second composition with propionic acid is used to enhance or modulate ketone body production, allowing for controlled blood ketone levels and therapeutic ketosis, with the second composition dose-dependently reducing ketone production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a ketogenic diet is used to raise blood ketone levels, then therapeutic effects are achieved, but patient compliance is low due to restrictive nature
Solution Approach 1:
The patent segments the ketone body supplementation approach by using specific compositions with defined fatty acid profiles (first composition with butyric/caproic acids, second composition with propionic acid) rather than requiring complete dietary restriction. This allows therapeutic effects to be achieved through targeted supplementation while maintaining greater dietary flexibility and patient compliance.
Solution Approach 2:
The patent introduces exogenous ketone body compositions as intermediary substances that mediate between the desired therapeutic ketosis state and the restrictive ketogenic diet. These compositions serve as alternative pathways to achieve therapeutic effects without requiring complete adherence to the restrictive diet, thereby improving patient compliance.
2Quantity of substance
If exogenous ketone bodies are used to establish or support nutritional ketosis, then blood ketone levels are raised, but variable blood ketone concentrations occur with temporarily unnecessarily high or ineffective levels
Solution Approach 1:
The patent employs dynamic control of ketone body release by using compositions with specific fatty acid profiles that can be administered at different doses and frequencies. The first composition (butyric/caproic acids) and second composition (propionic acid) can be adjusted to maintain blood ketone concentrations within a stable therapeutic range, avoiding temporarily unnecessarily high or ineffective levels.
Solution Approach 2:
The patent changes the chemical composition parameters of the ketone body supplements by using specific fatty acid profiles (C4-C6 fatty acids in first composition, C3 fatty acids in second composition). This parameter optimization allows for controlled and stable blood ketone concentrations while maintaining therapeutic effectiveness.
3Quantity of substance
If current ketone body compositions are used, then ketone body levels are increased, but adverse side-effects like gastrointestinal upset occur
Solution Approach 1:
The patent applies local quality by using specific fatty acid profiles (C4-C6 for first composition, C3 for second composition) that are better tolerated by the gastrointestinal system. These specific fatty acid compositions provide ketone body levels while minimizing gastrointestinal upset, as they are more similar to naturally occurring fatty acids in the diet.
Solution Approach 2:
The patent converts the potential harm of high ketone body levels causing gastrointestinal upset into a benefit by using compositions that provide ketone bodies through alternative pathways (fatty acid oxidation) that are gentler on the gastrointestinal system, thereby maintaining therapeutic effects while reducing adverse effects.
4Reliability
If restrictive ketogenic diets are used to control ketone levels, then therapeutic ketosis is achieved, but device complexity increases
Solution Approach 1:
The patent extracts the essential function of ketone body production from the complex restrictive ketogenic diet by using targeted compositions with specific fatty acid profiles. This allows therapeutic ketosis to be achieved through supplementation rather than complete dietary restriction, thereby reducing the complexity of dietary management.
Solution Approach 2:
The patent creates multi-functional compositions that can be used both as ketone body supplements and as dietary additives. The first composition (butyric/caproic acids) and second composition (propionic acid) can be integrated into various dietary contexts, providing therapeutic ketosis without requiring exclusive restrictive diet adherence, thus reducing overall system complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables sustained therapeutic ketosis with improved tolerance and sensory properties, reducing adverse effects and enhancing patient compliance by maintaining ketone body levels within a therapeutically effective range.
Implementation Method 1
Ketone bodies represent energy substrates for both peripheral tissues and the central nervous system. The two most abundant and physiologically significant ketone bodies are acetoacetate and p-hydroxybutyrate
Implementation Method 2
a second composition comprising propionic acid ketone body production is decreased
Data Source
AI summary
The invention relates to a first composition providing at least one of acetic acid or butyric acid for controlling ketosis associated with a ketogenic diet in a subject adhering to a ketogenic diet, wherein controlling ketosis involves a) administering the first composition, b) optionally administering a second composition comprising propionic acid to reduce ketone production/administering a second composition comprising propionic acid provided that blood ketone levels are above 3 mmol/L.